Potential key roles of tumour budding: a representative malignant pathological feature of non-small cell lung cancer and a sensitive indicator of prognosis
Main Authors: | Xin He, Jianguo Zhang, Li Qian, Jiahai Shi, Jia Feng, Shumin Lu, Yifei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/3/e054009.full |
Similar Items
-
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement
by: Qing-Yun Gao, et al.
Published: (2023-01-01) -
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer
by: Wenfeng Liang, et al.
Published: (2024-01-01) -
Circulating tumour cells in patients with lung cancer universally indicate poor prognosis
by: Fukang Jin, et al.
Published: (2022-12-01) -
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma
by: Rui Chen, et al.
Published: (2023-04-01) -
Distribution and characteristics of malignant tumours by lung lobe
by: Yngvar Nilssen, et al.
Published: (2024-03-01)